Glucose Biosensor Market Share, Opportunities, Industry 2030
Glucose Biosensor Market Share, Opportunities, Industry 2030
Segments - Glucose Biosensor Market by End-users (Hospitals, Homecare Diagnostics, Research Institutes, Diagnostic Centers, and Clinics) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
Upcoming
| Report ID :HC-597
| 4.4 Rating
| 64 Reviews
| 184 Pages
| Format :
Report Description
The global glucose biosensor market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing diabetic patients around the world. Diabetes is one of the most commonly occurred disease in world and is a key cause for high mortality rate worldwide.
Glucose biosensors have a wide range of use in manufacturing, the environmental, and biomedical applications. These biosensors are used in clinical medicine to track patients’ glucose levels in order to detect the irregularities of blood pressure and help treat diabetes. Diabetes is a metabolic disease that results in an elevated blood sugar level, which triggers a number of metabolic pathways linked to inflammation and apoptosis. Therefore, diabetic patients must constantly monitor their blood glucose levels in order to prevent complications. Due to simplicity, selectivity, specificity, and direct point-of-care assays, electrochemical biosensors especially those containing glucose oxidase (GOx) are considered to be the preferred devices for determining blood glucose. However, since enzyme immobilization on a solid electrode is inefficient, there are still problems in using enzyme-based glucose biosensors.
Many researchers have used nanomaterials with various structures to solve this issue. Owing to their high surface-area-to-volume ratios, which allow high loading and provide a sensitive microenvironment for stabilizing and preventing the leakage of immobilised enzymes, a variety of nanomaterials are used as glucose biosensors. Some of the common materials are nanoparticles (NPs), nanorods (NRs), nanotubes (NTs), nanowires (NTs), and nanosheets.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing prevalence of diabetes worldwide is expected to boost the demand for self-monitoring portable devices. This is expected to boost the market during the forecast period.
- Increasing public awareness of diabetes as well as preferring early diagnosis and prevention are anticipated to spur the market growth.
- Development of advanced and innovative devices for glucose diagnosis is projected to fuel the market expansion.
- Availability of alternative techniques such as laboratories tests for monitoring the glucose levels is estimated to impede the market growth.
- Increasing investment on R&D by key players for the development of cost-effective, precise, and efficient devices is anticipated to offer lucrative opportunities for the market players.
Scope of the Report
The report on the global glucose biosensor market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Glucose Biosensor Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | End-users (Hospitals, Homecare Diagnostics, Research Institutes, Diagnostic Centers, and Clinics) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Abbott; Roche; Medtronic; Bio-Rad Laboratories, Inc.; DuPont; Biosensors International Group, Ltd.; Cytiva; Dexcom, Inc.; Lifescan IP Holdings, LLC; Masimo; Nova Biomedical; and Universal Biosensors |
Market Segment Insights
Homecare diagnostics segment is expected to hold a key market share
Based on end-users, the global glucose biosensor market is segmented into hospitals, homecare diagnostics, research institutes, diagnostic centers, and clinics. The homecare diagnostics segment is expected to hold a key share of the market during the forecast period owing to its portability, easy-to-use, cost-effective, and provides quick results. Point-of-care devices such as hand-held glucose meters are widely used in the homecare diagnostic segment. The rising use of these devices decreases the number of hospital visits and saves a huge amount of money spending in the hospitals or clinics, thereby, boosting the segment growth.
North America is anticipated to dominate the market
On the basis of regions, the glucose biosensor market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market expanding at a healthy CAGR during the forecast period due to increasing prevalence of diabetes and rising adoption of advanced technology in the clinical treatment. Diabetes is expected to be one of the primary causes of illness and death in this region. On the other hand, Asia-Pacific is expected to exhibit a rapid growth rate in the coming years due to increasing prevalence of diabetes in countries such as China and India.
Segments
Segments Covered in the Report
The global glucose biosensor market has been segmented on the basis of
End-users
- Hospitals
- Homecare Diagnostics
- Research Institutes
- Diagnostic Centers
- Clinics
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott
- Roche
- Medtronic
- Bio-Rad Laboratories, Inc.
- DuPont
- Biosensors International Group, Ltd.
- Cytiva
- Dexcom, Inc.
- Lifescan IP Holdings, LLC
- Masimo
- Nova Biomedical
- Universal Biosensors
Competitive Landscape
Key players competing in the glucose biosensor market are Abbott; Roche; Medtronic; Bio-Rad Laboratories, Inc.; DuPont; Biosensors International Group, Ltd.; Cytiva; Dexcom, Inc.; Lifescan IP Holdings, LLC; Masimo; Nova Biomedical; and Universal Biosensors. In order to ensure competitiveness and growth, the companies are increasingly engaged in new product creation, technical innovations, alliances, joint projects, and collaborations to increase their market position and expand customer base.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Glucose Biosensor Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glucose Biosensor Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glucose Biosensor Market - Supply Chain
4.5. Global Glucose Biosensor Market Forecast
4.5.1. Glucose Biosensor Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glucose Biosensor Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Glucose Biosensor Market Absolute $ Opportunity
5. Global Glucose Biosensor Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Glucose Biosensor Market Size and Volume Forecast by End Users
5.3.1. Hospitals
5.3.2. Homecare Diagnostics
5.3.3. Research Institutes
5.3.4. Diagnostic Centers
5.3.5. Clinics
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Glucose Biosensor Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Glucose Biosensor Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Glucose Biosensor Demand Share Forecast, 2019-2026
7. North America Glucose Biosensor Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Glucose Biosensor Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Glucose Biosensor Market Size and Volume Forecast by End Users
7.4.1. Hospitals
7.4.2. Homecare Diagnostics
7.4.3. Research Institutes
7.4.4. Diagnostic Centers
7.4.5. Clinics
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Glucose Biosensor Demand Share Forecast, 2019-2026
8. Latin America Glucose Biosensor Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Glucose Biosensor Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Glucose Biosensor Market Size and Volume Forecast by End Users
8.4.1. Hospitals
8.4.2. Homecare Diagnostics
8.4.3. Research Institutes
8.4.4. Diagnostic Centers
8.4.5. Clinics
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Glucose Biosensor Demand Share Forecast, 2019-2026
9. Europe Glucose Biosensor Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Glucose Biosensor Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Glucose Biosensor Market Size and Volume Forecast by End Users
9.4.1. Hospitals
9.4.2. Homecare Diagnostics
9.4.3. Research Institutes
9.4.4. Diagnostic Centers
9.4.5. Clinics
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Glucose Biosensor Demand Share Forecast, 2019-2026
10. Asia Pacific Glucose Biosensor Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Glucose Biosensor Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Glucose Biosensor Market Size and Volume Forecast by End Users
10.4.1. Hospitals
10.4.2. Homecare Diagnostics
10.4.3. Research Institutes
10.4.4. Diagnostic Centers
10.4.5. Clinics
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Glucose Biosensor Demand Share Forecast, 2019-2026
11. Middle East & Africa Glucose Biosensor Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Glucose Biosensor Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Glucose Biosensor Market Size and Volume Forecast by End Users
11.4.1. Hospitals
11.4.2. Homecare Diagnostics
11.4.3. Research Institutes
11.4.4. Diagnostic Centers
11.4.5. Clinics
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Glucose Biosensor Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Glucose Biosensor Market: Market Share Analysis
12.2. Glucose Biosensor Distributors and Customers
12.3. Glucose Biosensor Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott
12.4.2. Roche
12.4.3. Medtronic
12.4.4. Bio-Rad Laboratories, Inc.
12.4.5. DuPont
12.4.6. Biosensors International Group, Ltd.
12.4.7. Cytiva
12.4.8. Dexcom, Inc.
12.4.9. Lifescan IP Holdings, LLC
12.4.10. Masimo
Methodology
Related Reports
Some other reports from this category!
Our Clients
